Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R James White

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Expert Opinion on Pharmacotherapy|October 13, 2011
Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertensionMatthew Ferrantino, R James White
Canadian Journal of Physiology and Pharmacology|August 21, 2010
Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinaseDavid F Meoli, R James White
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 4, 2009
Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: requirement of calcium/calmodulin-dependent protein kinase IIDavid F Meoli, R James White
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2008
Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertensionMichael S Gough, R James White
Respiratory Medicine Case Reports|May 2, 2022
Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertensionCarlo Arevalo, R James White, Daniel Lachant
Respiratory Medicine|September 11, 2021
Vasodilator use in precapillary pulmonary hypertension with end stage kidney disease: A single center experienceCarlo Arevalo, R James White, Thu Le, et al.
Drug Discovery Today|April 22, 2014
Thrombosis, platelets, microparticles and PAH: more than a clotKatie L Lannan, Richard P Phipps, R James White
Pulmonary Circulation|February 10, 2025
Heart Rate Variability in Pulmonary Arterial HypertensionBishal Gyawali, Dominick Roto, Michael Lachant, et al.
Pulmonary Circulation|March 13, 2014
Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesicsR James White, Yana Levin, Kathleen Wessman, et al.
Pulmonary Circulation|January 20, 2026
Supplemental Oxygen Decreases Cardiac Effort in Pulmonary Arterial HypertensionKyle Norton, Bishal Gyawali, Deborah Haight, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Expert Opinion on Pharmacotherapy|October 13, 2011
Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertensionMatthew Ferrantino, R James White
Canadian Journal of Physiology and Pharmacology|August 21, 2010
Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinaseDavid F Meoli, R James White
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 4, 2009
Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: requirement of calcium/calmodulin-dependent protein kinase IIDavid F Meoli, R James White
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2008
Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertensionMichael S Gough, R James White
Respiratory Medicine Case Reports|May 2, 2022
Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertensionCarlo Arevalo, R James White, Daniel Lachant
Respiratory Medicine|September 11, 2021
Vasodilator use in precapillary pulmonary hypertension with end stage kidney disease: A single center experienceCarlo Arevalo, R James White, Thu Le, et al.
Drug Discovery Today|April 22, 2014
Thrombosis, platelets, microparticles and PAH: more than a clotKatie L Lannan, Richard P Phipps, R James White
Pulmonary Circulation|February 10, 2025
Heart Rate Variability in Pulmonary Arterial HypertensionBishal Gyawali, Dominick Roto, Michael Lachant, et al.
Pulmonary Circulation|March 13, 2014
Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesicsR James White, Yana Levin, Kathleen Wessman, et al.
Pulmonary Circulation|January 20, 2026
Supplemental Oxygen Decreases Cardiac Effort in Pulmonary Arterial HypertensionKyle Norton, Bishal Gyawali, Deborah Haight, et al.
Pageof 7